BioNexus Gene Lab Corp. (BGLC) Fail-to-Deliver (FTD) Analysis | Settlement Risk & Short Interest - Stocknear

BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
4.73
-0.23 (-4.73%)
At close: Sep 09, 2025, 9:54 AM

BioNexus Gene Lab Fail-to-Deliver

Total FTD Shares
313.44K
Above Average
FTD / Avg. Volume
15.45%
Low Impact
1-Year Change
> 100%
Positive Trend

FTD Chart

As of Jul 31, 2025, BioNexus Gene Lab Corp. has 313,436 shares failed to deliver, representing 15.45% of the average daily volume of 2,029,085 shares.

FTD History

Date Price FTD Shares % Change
Jul 31, 2025 6.93 313,436 +31624.29%
Jun 10, 2025 3.14 988 -68.25%
May 30, 2025 4.29 3,112 +3889.74%
Apr 30, 2025 2.85 78 -99.92%
Mar 31, 2025 2.36 94,627 +13673.94%
Feb 27, 2025 3.35 687 -69.05%
Jan 31, 2025 4.07 2,220 -96.37%
Dec 24, 2024 2.43 61,184 +6246.89%
Nov 26, 2024 2.44 964 -89.62%
Oct 31, 2024 3.6 9,288 -62.83%
Sep 27, 2024 4.44 24,988 +24.05%
Aug 28, 2024 4.58 20,143 +11216.29%
Jul 31, 2024 4.88 178 -93.77%
Jun 27, 2024 4.61 2,858 -19.38%
May 30, 2024 4.36 3,545 +406.43%
Apr 25, 2024 5.93 700 +4566.67%
Mar 22, 2024 7.25 15 -99.81%
Feb 27, 2024 7.1 7,935 +5261.49%
Jan 30, 2024 4.75 148 -97.95%
Dec 29, 2023 5.3 7,237 -98.18%
Nov 30, 2023 9.5 397,823 +11518.66%
Oct 31, 2023 4.19 3,424 +68380.00%
Sep 29, 2023 8.7 5 -99.37%
Aug 10, 2023 11.4 789 -97.40%
Jul 31, 2023 22.3 30,366 +1429.77%
Jun 27, 2023 0.45 1,985 +499.70%
May 31, 2023 34.5 331 n/a